| ||||||
| 1617 JFK Blvd, Philadelphia, PA, 19103-1821, US. TEL: 215-988-0080 http://www.hemispherx.net | ||||||
| Last Sale | Net Change | % Change | Volume | Last Updated | ||
|---|---|---|---|---|---|---|
| $1.02 | 0.01 | 0.97 | 1,097,632 | 11/20/09 4:00 PM ET | ||
| ||||||||||||||||||||||
 |
|
||||||||||||||||||||||
| ||||
| Security Type | Common Stock | Specialist | 076 | |
| Industry | Health Services, Pharmaceuticals, and Medical Diagnostics | Trading Post | 2 | |
| Primary Exchange | NYSE Amex | SEC Filings | ||
| ||||
| Description |
|
Hemispherx Biopharma, Inc., a biopharmaceutical company, engages in the clinical development, manufacture, marketing, and distribution of new drug therapies for the treatment of viral and immune based chronic disorders. The company's products include Alferon N Injection for the treatment of genital warts; and Ampligen, an experimental drug that is in human clinical development for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, HIV, renal cell carcinoma, and malignant melanoma. Its products also comprise Alferon LDO, a low-dose, oral liquid formulation of natural alpha interferon for influenza and viral diseases, which is in the early stage of development; and Oragens for the treatment of viral diseases and disorders of the immune system. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania. |
| Quote |
| ||||
| Last Sale | $1.02 (11/20/09) | |||
| Net Change | 0.01 | |||
| % Change | 0.97 | |||
| Previous Close | $1.03 | |||
| Today’s Open | $1.01 | |||
| Today’s High | $1.03 | |||
| Today’s Low | $0.98 | |||
| Volume | 1,097,632 | |||
| 52 Week High | $4.54 | |||
| 52 Week Low | $0.26 | |||
| ||||
| Chart |
| 3mo | 6mo | 12mo | 24mo | 36mo | 48mo | 60mo |
|
| Click here to view the data behind the chart. |
| Fundamentals |
|
||||
| P/E ratio | -9.00 | Short Interest | 13,889,243 | |
| Earnings Per Share | 0.00 | Current yield | N.A. | |
| Shares Outstanding | 132,724,000 | Dividend Info | ||
| Market Cap | 135,378,480 | |||
|
||||
|
|
